| Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course RG DiNatale, AN Gorelick, V Makarov, KA Blum, AW Silagy, B Freeman, ... European urology focus 7 (2), 381-389, 2021 | 33 | 2021 |
| Genomic and metabolic hallmarks of SDH-and FH-deficient renal cell carcinomas A Yoo, C Tang, M Zucker, K Fitzgerald, RG DiNatale, PM Rappold, ... European urology focus 8 (5), 1278-1288, 2022 | 16 | 2022 |
| MIRTH: Metabolite imputation via rank-transformation and harmonization BA Freeman, S Jaro, T Park, S Keene, W Tansey, E Reznik Genome biology 23 (1), 184, 2022 | 3 | 2022 |
| Resource-efficient pooled sequencing expands translational impact in solid tumors RG DiNatale, R Mano, V Makarov, N Rusk, E Drill, A Winer, A Sankin, ... bioRxiv, 2021 | 1 | 2021 |
| A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT). SA Funt, A Knezevic, BA Freeman, M Bolos, V Martorana, M Donoghue, ... Journal of Clinical Oncology 41 (16_suppl), 5040-5040, 2023 | | 2023 |
| Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery. J Ma, L del Balzo, SS Khaleel, J Flynn, Z Zhang, MH Voss, B Freeman, ... Journal of Clinical Oncology, 2022 | | 2022 |
| PD01-08 COMPARISON OF MUTATIONAL PROFILE OF PRIMARY VERSUS ORGAN-SPECIFIC METASTATIC TUMORS IN CLEAR CELL RENAL CELL CARCINOMA S Khaleel, R DiNatale, B Freeman, R Kotecha, R Motzer, P Russo, ... Journal of Urology 207 (Supplement 5), e32, 2022 | | 2022 |
| MP39-08 GENOMIC AND METABOLIC HALLMARKS OF TCA-CYCLE-MUTANT RENAL CELL CARCINOMAS A Yoo, C Tang, M Zucker, K Fitzgerald, P Rappold, K Weiss, B Freeman, ... The Journal of Urology 206 (Supplement 3), e707-e707, 2021 | | 2021 |
